Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast Calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Clinical trial imaging industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Service trends
2.1.4 Imaging technique trends
2.1.5 Therapeutic area trends
2.1.6 End user trends
Chapter 3 Clinical Trial Imaging Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing number of clinical studies
3.2.1.2 Increasing number of contract research organizations (CROS)
3.2.1.3 Rise in R&D expenditure
3.2.2 Industry pitfalls & challenges
3.2.2.1 Clinical study expenses
3.2.2.2 High cost associated with the imaging techniques and potential exposure to radiation
3.3 Growth potential analysis
3.3.1 By service
3.3.2 By imaging technique
3.3.3 By therapeutic area
3.3.4 By end user
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Clinical Trial Imaging Market Estimates and Forecast, By Service, 2018-2032 (USD Million)
5.1 Key trends, by service
5.2 Clinical trial design and consultation services
5.3 Reading and analytical services
5.4 Operational imaging
5.5 System and technology support services
5.6 Project and data management
Chapter 6 Clinical Trial Imaging Market Estimates and Forecast, By Imaging Techniques, 2018-2032 (USD Million)
6.1 Key trends, by imaging technique
6.2 Magnetic resonance imaging (MRI)
6.3 Computed tomography (CT) scan
6.4 Ultrasound
6.5 Positron emission tomography (PET)
6.6 Echocardiography (ECG)
6.7 X-ray
6.8 Other imaging techniques
Chapter 7 Clinical Trial Imaging Market Estimates and Forecast, By Therapeutic Area, 2018-2032 (USD Million)
7.1 Key trends, by therapeutic area
7.2 Central nervous system
7.3 Oncology
7.4 Infectious disease
7.5 Endocrinology & metabolic disorders
7.6 Diabetes
7.7 Musculoskeletal
7.8 Cardiovascular diseases
7.9 Respiratory
7.10 Gastroenterology
7.11 Nonalcoholic steatohepatitis (NASH)
7.12 Other therapeutic areas
Chapter 8 Clinical Trial Imaging Market Estimates and Forecast, By End User, 2018-2032 (USD Million)
8.1 Key trends, by end user
8.2 Biotechnology and pharmaceutical companies
8.3 Medical devices manufacturers
8.4 Contract research organization (CRO)
8.5 Academics & government research institutes
8.6 Other end users
Chapter 9 Clinical Trial Imaging Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 ICON PLC
10.2 Medidata
10.3 WCG Clinical
10.4 Radiant Sage
10.5 Biomedical Systems Corporation
10.6 Biotelemetry, Inc.
10.7 Image Core Lab
10.8 WCG Clinical
10.9 Ixico PLC
10.10 Medspace Holdings Inc.
10.11 Resonance Health Limited Median Technologies
10.12 WorldCare Clinical
10.13 Navitas Clinical Research, Inc
